Fresh vs cryopreserved cell preparations: what changes and what to test for

The convenience of cryopreserved cell preparations is real — they ship globally, they reserve known-good characterization, they fit a research timeline that does not depend on a donor showing up on the right Tuesday. The trade-off is that cryopreservation changes things. Some of those changes resolve within hours; some do not resolve at all. Knowing which is which makes the difference between a clean experiment and a confounded one.

What measurably changes after a freeze-thaw cycle

Membrane integrity. Even with optimal cryoprotectant (typically 5–10% DMSO) and controlled-rate freezing, a fraction of cells lose membrane integrity during the thaw. Trypan blue or 7-AAD viability measured immediately post-thaw is typically 80–95% in well-controlled lots; the "5–20% loss" is real biology.
Mitochondrial polarization. Membrane potential drops transiently during thaw and recovers over 4–24 hours under optimal recovery conditions. Energy-intensive functional assays run on cells <4 hours post-thaw will under-report the population's capability.
Surface marker expression. Some markers (notably HLA-DR on MSCs) can transiently up-regulate during thaw stress. Re-checking the ISCT identity panel 24 hours after thaw, not at thaw, gives a more representative reading.
Apoptotic priming. Even cells that pass the viability dye exclusion test can be metabolically primed for apoptosis. Annexin V/PI dual-stain at 24 and 48 hours post-thaw catches the fraction that will drop out of culture.
DMSO carryover. Residual DMSO is biologically active. For sensitive downstream assays (induced differentiation, EV harvest, transcriptomic profiling), the standard wash protocol matters.

What does NOT change appreciably

Genomic integrity. With optimal cryoprotectant and controlled-rate freezing, no measurable shift in karyotype or gross chromosomal stability through reasonable freeze-thaw cycle counts.
Donor-attributable transcriptomic identity. The cell population's underlying transcriptional program re-emerges after recovery; donor signature is preserved.
Differentiation potential under conditions where it is going to be exercised. Tri-lineage capacity is preserved if the lot is given recovery time before the differentiation protocol is started.

When to choose fresh over cryopreserved

Studies where the readout is hours, not days, after cell delivery (acute paracrine signaling, immediate immunomodulation assays). Recovery dynamics confound the readout.
Mitochondrial transfer studies — fresh-isolated MSCs transfer mitochondria more efficiently than immediately-post-thaw lots.
Comparative pharmacology where freshness is one of the variables. Mixing fresh and cryo lots in the same study introduces a known confounder.

When cryopreserved is the right answer

Studies with planned recovery windows (24–48+ hours of recovery culture before any readout).
Multi-site or multi-week protocols where donor-source consistency matters more than freshness.
Studies where you intend to qualify a single lot extensively and then use it for the duration of the program — the only practical way to do this is with a banked, cryopreserved lot.

What to ask the supplier for

Cryopreservation protocol (cryoprotectant, freezing rate, storage temperature)
Recommended thaw and recovery procedure
Post-thaw viability data — both immediately and at 24 hours, ideally on representative lots
Recommended assay window relative to thaw time
Lot-to-lot variability data from previous lots run by other customers, where available

Where ExoBioCorp fits